Italia markets close in 8 hours 29 minutes
FTSE MIB
34.447,57 +297,07 (+0,87%) Dow Jones
38.111,48 -330,02 (-0,86%) Nasdaq
16.737,08 -183,52 (-1,08%) Nikkei 225
38.487,90 +433,80 (+1,14%) Petrolio
77,83 -0,08 (-0,10%) Bitcoin EUR
63.057,74 +433,36 (+0,69%)
ARCA biopharma, Inc. (ABIO)
NasdaqCM - NasdaqCM Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 04:00PM EDT
Dopo ore:
| Chiusura precedente | 3,4300 |
| Aperto | 3,4800 |
| Denaro | 3,4500 x 200 |
| Domanda | 3,5300 x 100 |
| Min-Max giorno | 3,3840 - 3,5100 |
| Intervallo di 52 settimane | 1,5600 - 4,4900 |
| Volume | |
| Media Volume | 1.450.625 |
| Capitalizzazione | 50,34M |
| Beta (mensile su 5 anni) | 0,88 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,4200 |
| Prossima data utili | 19 lug 2024 - 23 lug 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireARCA biopharma Announces Second Quarter 2023 Financial Results
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., July 21, 2023 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported second quarter 2023 financial results and provided a corporate update. In April 2022, the Board of Di
© 2024 Yahoo. Tutti i diritti riservati.